“Support on current drug utilizations and benchmarking of emerging therapy, greatly helped us in narrowing down on patient share estimations for internal calculations ״

Santen PharmaDirector

“Patient share for approved therapies are estimated perfectly. Indeed it's great pieces of work. I liked the way segmentation was shown and patient flow was discussed״

Vicore PharmaDirector

“Happy to read the market insight report, really informative and applied to build marketing strategy״

NewronDirector

“This is the first time I worked with Thelansis, I could say the team is truly professional, Cheers guys ״

SanquinDirector

“ We want to congratulate team Thelansis for their continuous support during this tough time ״

WEX TherapeuticsDirector

"We are really fortunate to interact with Thelansis' Forecasting team, well seasoned professionals who understand what's the actual need "

Reata PharmaceuticalsVice President

" We are really fortunate to interact with Thelansis' Forecasting team, well seasoned professionals who understand what's the actual need "

Stemline TherapeuticsVice President- Marketing

"Some great piece of patient based forecast model; and market assumptions. Tying up beautifully with the payer's insights "

CamurusDirector

"Liked the way the outcome was structured. Regulatory assessment was spot-on. Country-wise regulatory scenarios were gold to us at this point"

Asarina PharmaDirector

"Satisfied with the companies core competency around Clinical Trial Outcome analysi"

Acadia PharmaceuticalsDirector